Atlas Trials

FX-322 in Sensorineural Hearing Loss

Clinical trial NCT03616223 · COMPLETED

Trial details

NCT number
NCT03616223
Sponsor
Frequency Therapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Sensorineural Hearing Loss
Start date
2018-07-03
Primary completion
2018-12-18
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.